Copyright
©The Author(s) 2019.
World J Hypertens. Mar 12, 2019; 9(1): 1-16
Published online Mar 12, 2019. doi: 10.5494/wjh.v9.i1.1
Published online Mar 12, 2019. doi: 10.5494/wjh.v9.i1.1
Table 1 Causes of secondary hypertension and initial screening tests1
| Hyperaldosteronism | Serum renin-aldosterone ratio |
| Renal parenchymal disease | Serum creatinine |
| Obstructive sleep apnea | Polysomnography |
| Pheochromocytoma | Serum metanephrine and 24-h urine catecholamines |
| Renal artery stenosis | Renal artery duplex |
| Coarctation of the aorta | CT angiogram |
| Cushing’s disease | 24-h free urinary cortisol and late-night salivary cortiso1 |
| Thyroid disease | TSH and freeT4 |
| Acromegaly | Serum growth hormone |
| NSAIDs |
| Estrogens/Progestins |
| Anabolic Steroids |
| Corticosteroids |
| COX-2 Inhibitors |
| SSRI/SNRI |
| Tricyclic antidepressants |
| Lithium |
| Buspirone |
| Carbamazepine |
| Calcineurin inhibitors |
| Pseudoephedrine |
| Amphetamine derivatives |
| 1Chemotherapy agents |
| Caffeine |
| Methamphetamines |
| Cocaine |
| Ginseng, St John’s Wort, Ephedra, Yohimbine |
| Alcohol |
- Citation: Schmidt K, Kelley W, Tringali S, Huang J. Achieving control of resistant hypertension: Not just the number of blood pressure medications. World J Hypertens 2019; 9(1): 1-16
- URL: https://www.wjgnet.com/2220-3168/full/v9/i1/1.htm
- DOI: https://dx.doi.org/10.5494/wjh.v9.i1.1
